ARMP Armata Pharmaceuticals, Inc.

Fundamentals / CIK 0000921114 / USD

Armata Pharmaceuticals, Inc. reported $84.48M in total assets and a net loss of $110.6M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ARMP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$162.5MFY 2016 Net Income: -$18.84M2016FY 2017 Net Income: -$12.84M2017FY 2018 Net Income: -$16.70M2018FY 2019 Net Income: -$19.48M2019FY 2020 Net Income: -$22.18M2020FY 2021 Net Income: -$23.16M2021FY 2022 Net Income: -$36.92M2022FY 2023 Net Income: -$69.05M2023FY 2024 Net Income: -$18.92M2024FY 2025 Net Income: -$173.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $23.72M $34.43M $33.77M $35.02M $20.02M $14.44M $9.82M $8.37M $2.88M $5.68M
Total Operating Expenses $41.54M $47.61M $45.42M $42.45M $28.30M $22.41M $19.75M $17.66M $16.27M $23.64M
Operating Income -$36.63M -$42.44M -$40.89M -$36.95M -$23.82M -$21.59M -$19.75M -$17.66M -$16.16M -$23.38M
EBITDA -$35.10M -$41.11M -$39.92M -$36.05M -$22.65M -$20.47M -$18.40M -$16.28M -$15.78M -$23.01M
Interest Income -- -- $179K $29K $5.0K $28K $96K $245K -- --
Interest Expense -- -- $2.63M $0 $64K $628K $931K $1.01M -- $6.0K
Income Before Tax -$173.8M -$18.92M -$69.05M -$37K -$23.16M -$22.18M -$19.48M -$16.70M -$14.14M -$19.39M
Income Tax Expense -- -- -- -- -- -- -- -$328K -$1.30M -$556K
Net Income -$173.8M -$18.92M -$69.05M -$36.92M -$23.16M -$22.18M -$19.48M -$16.70M -$12.84M -$18.84M
Basic EPS -$4.80 -$0.52 -$1.91 -$1.08 -$0.96 -$1.35 -$2.49 -$50.28 -$1,395.17 -$17,123.82
Diluted EPS -$4.80 -$0.89 -$1.91 -$1.08 -$0.96 -$1.35 -$2.55 -$50.28 -$1,513.17 -$17,123.82
Basic Shares Outstanding 36.2M 36.2M 36.1M 34.3M 24.1M 16.4M 7.8M 332.2K 9.2K 1.4K
Diluted Shares Outstanding 36.2M 59.1M 36.1M 34.3M 24.1M 16.4M 8.0M 332.2K 9.5K 1.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $6.83M $7.59M $6.11M $6.07M $5.82M $6.39M $5.43M $8.45M
Total Operating Expenses $10.55M $12.82M $9.57M $14.91M $8.94M $9.01M $8.68M $11.77M
Operating Income -$7.38M -$10.31M -$8.79M -$13.82M -$7.78M -$6.84M -$8.19M -$10.54M
EBITDA -$6.78M -$9.81M -$8.33M -$13.40M -$7.41M -$6.48M -$7.81M -$10.16M
Income Tax Expense $0 $0 $0 -- $0 $0 $0 --
Net Income $54.86M $74.14M -$115.3M -$124.3M -$26.68M -$16.30M -$6.53M $2.60M
Basic EPS $1.15 $2.02 -$3.16 -- -$0.74 -$0.45 -$0.18 --
Diluted EPS -$0.24 -$0.27 -$3.16 -- -$0.74 -$0.45 -$0.20 --
Basic Shares Outstanding 37.2M 36.7M 36.5M -- 36.2M 36.2M 36.2M --
Diluted Shares Outstanding 62.7M 62.0M 36.5M -- 36.2M 36.2M 59.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $8.69M $9.29M $13.52M $14.85M $10.29M $9.65M $6.03M $9.66M $5.13M $5.13M
Cash & Short-Term Investments $8.69M $9.29M $13.52M $14.85M $10.29M $9.65M $6.03M $9.66M $5.13M $5.13M
Accounts Receivable, Net -- -- -- -- -- -- -- -- -- $12K
Other Current Assets $472K $744K $3.36M $8.53M -- -- -- -- -- --
Total Current Assets $10.67M $11.31M $19.15M $27.05M $14.99M $10.85M $6.66M $10.36M $5.38M $6.31M
Property, Plant & Equipment, Net $12.19M $13.24M $12.56M $3.62M $2.22M $2.05M $2.19M $3.25M $816K $1.07M
Goodwill $3.49M $3.49M $3.49M $3.49M $3.49M $3.49M $3.49M -- -- --
Intangible Assets $10.26M $10.26M $10.26M $10.26M $10.26M $10.26M $10.26M $2.73M $4.66M $10.46M
Other Non-Current Assets $973K $975K $2.47M $2.43M $1.75M $887K $135K $136K -- --
Total Non-Current Assets $66.21M $75.13M $79.21M $68.79M $54.77M $28.67M $18.80M $4.18M $5.75M $11.84M
Total Assets $76.88M $86.44M $98.36M $95.83M $69.77M $39.52M $25.45M $14.54M $11.14M $18.15M
Accounts Payable $921K $766K $1.58M $1.68M $1.14M $956K $547K $415K $578K $1.06M
Other Current Liabilities $487K $529K $523K -- -- -- -- -- -- $185K
Total Current Liabilities $8.95M $48.25M $16.46M $24.87M $4.81M $6.71M $4.88M $2.03M $1.97M $3.54M
Total Non-Current Liabilities $286.5M $86.21M $114.0M $34.88M $39.56M $13.95M $5.98M $4.82M $1.44M $4.89M
Total Liabilities $295.5M $134.5M $130.4M $59.75M $44.37M $20.66M $10.86M $6.85M $3.41M $8.43M
Total Debt (incl. Leases) $31.10M $32.12M $38.06M $48.81M $37.99M $12.43M $2.86M -- -- --
Common Stock $364K $362K $361K $361K $271K $187K $99K $51K $95K $16K
Retained Earnings -$501.5M -$327.7M -$308.8M -$239.8M -$202.9M -$179.7M -$157.5M -$138.0M -$394.2M -$381.4M
Total Stockholders' Equity -$218.6M -$48.02M -$32.06M $36.08M $25.40M $18.86M $14.59M $7.69M $24.34M $9.72M
Total Equity -$218.6M -$48.02M -$32.06M $36.08M $25.40M $18.86M $14.59M $7.69M $24.34M $9.72M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $18.32M $23.95M $4.75M $8.69M $14.76M $4.33M $11.69M $9.29M
Cash & Short-Term Investments $18.32M $23.95M $4.75M $8.69M $14.76M $4.33M $11.69M $9.29M
Other Current Assets $3.21M $2.53M $47K $472K $759K $2.17M $238K $744K
Total Current Assets $22.60M $27.16M $5.95M $10.67M $16.93M $7.52M $13.17M $11.31M
Property, Plant & Equipment, Net $10.80M $11.23M $11.78M $12.19M $12.56M $12.66M $12.88M $13.24M
Goodwill $3.49M $3.49M $3.49M $3.49M $3.49M $3.49M $3.49M $3.49M
Intangible Assets $10.26M $10.26M $10.26M $10.26M $10.26M $10.26M $10.26M $10.26M
Other Non-Current Assets $836K $813K $813K $973K $973K $973K $975K $975K
Total Non-Current Assets $61.88M $62.79M $63.85M $66.21M $72.59M $73.27M $74.08M $75.13M
Total Assets $84.48M $89.95M $69.80M $76.88M $89.52M $80.79M $87.25M $86.44M
Accounts Payable $587K $1.19M $660K $921K $1.28M $965K $981K $766K
Other Current Liabilities $459K $195K $372K $487K $503K $137K $337K $529K
Total Current Liabilities $186.8M $250.2M $9.23M $8.95M $139.9M $120.1M $110.5M $48.25M
Total Non-Current Liabilities $71.83M $70.92M $372.2M $286.5M $45.15M $30.21M $30.49M $86.21M
Total Liabilities $258.6M $321.1M $381.4M $295.5M $185.1M $150.3M $141.0M $134.5M
Total Debt (incl. Leases) $30.11M $30.45M $30.78M $31.10M $31.36M $31.62M $31.88M $32.12M
Common Stock $372K $371K $366K $364K $362K $362K $362K $362K
Retained Earnings -$487.9M -$542.7M -$616.9M -$501.5M -$377.2M -$350.6M -$334.3M -$327.7M
Total Stockholders' Equity -$174.1M -$231.2M -$311.6M -$218.6M -$95.59M -$69.50M -$53.78M -$48.02M
Total Equity -$174.1M -$231.2M -$311.6M -$218.6M -$95.59M -$69.50M -$53.78M -$48.02M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$173.8M -$18.92M -$69.05M -$36.92M -$23.16M -$22.18M -$19.48M -$16.70M -$12.84M -$18.84M
Depreciation & Amortization $1.53M $1.32M $972K $892K $1.17M $1.11M $1.35M $1.38M $374K $369K
Stock-Based Compensation $2.61M $2.89M $938K $3.10M $2.88M $3.48M $4.27M $46K $700K $2.00M
Change in Receivables -- -- -- -- -- -$467K -- -- -- $100K
Operating Cash Flow -$25.76M -$37.55M -$47.42M -$32.48M -$23.57M -$18.27M -$15.58M -$10.63M -$9.19M -$10.61M
Capital Expenditure -$542K -$1.88M -$8.14M -$2.21M -$1.30M -$824K -$224K -$875K -$58K -$279K
Free Cash Flow -$26.30M -$39.43M -$55.57M -$34.69M -$24.88M -$19.09M -$15.81M -$11.50M -$9.25M -$10.88M
Purchases of Investments -- -- -- -- -- -- -- -$3.39M -- --
Investing Cash Flow -$542K -$1.88M -$8.13M -$2.21M -$1.30M -$824K $2.88M $8.81M -$58K -$279K
Common Stock Issued -- -- -- $44.39M $26.32M $22.89M $9.97M $12.25M $9.35M $7.57M
Dividends Paid -- -- -- -- -- -- -- -- -- -$80K
Financing Cash Flow $25.61M $34.96M $53.99M $44.02M $25.52M $23.21M $8.97M $12.45M $8.67M $7.23M
Net Change in Cash -$693K -$4.47M -$1.57M $9.32M $639K $4.12M -$3.73M -$1.81M -$579K -$3.66M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $54.86M $74.14M -$115.3M -$124.3M -$26.68M -$16.30M -$6.53M $2.60M
Depreciation & Amortization $600K $500K $457K $418K $370K $366K $377K $380K
Stock-Based Compensation $2.22M $3.39M $1.07M $632K $622K $575K $781K $354K
Operating Cash Flow -$5.52M -$8.67M -$5.78M -$6.67M -$4.30M -$7.21M -$7.58M -$7.93M
Capital Expenditure -$91K -$17K -$63K -$52K -$242K -$149K -$99K $77K
Free Cash Flow -$5.61M -$8.68M -$5.84M -$6.73M -$4.54M -$7.36M -$7.68M -$7.85M
Investing Cash Flow -$91K -$17K -$63K -$52K -$242K -$149K -$99K $77K
Financing Cash Flow -$28K $27.88M $641K $658K $14.97M $0 $9.99M $0
Net Change in Cash -$5.63M $19.20M -$5.20M -$6.07M $10.43M -$7.36M $2.31M -$7.85M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -- -- -102.3% -91.2% -117.6% -133.5% -217.1% -52.7% -193.7%
Return on Assets (ROA) -226.1% -21.9% -70.2% -38.5% -33.2% -56.1% -76.5% -114.8% -115.3% -103.8%
Current Ratio 1.19x 0.23x 1.16x 1.09x 3.11x 1.62x 1.36x 5.10x 2.74x 1.78x
Quick Ratio 0.97x 0.19x 0.82x 0.60x 2.14x 1.44x 1.24x 4.76x 2.61x 1.45x
Debt to Equity -- -- -- 1.35x 1.50x 0.66x 0.20x -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -100.1% -- -- --
10Y Net Income / Share Growth -- -100.0% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Assets (ROA) -131.0% -213.6% -404.9% -226.1% -52.4% -31.8% -0.5% -21.9%
Current Ratio 0.12x 0.11x 0.64x 1.19x 0.12x 0.06x 0.12x 0.23x
Quick Ratio 0.10x 0.10x 0.52x 0.97x 0.11x 0.04x 0.11x 0.19x
Net Income Growth (YoY) -- -- -- -4880.7% -- -281.3% -- --
EPS Growth (YoY) -- -- -- -- -- -280.0% -- --
Source: SEC EDGAR CompanyFacts (CIK 0000921114) · from March 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal